Phenomics Australia in vitro node the Monash BDI Organoid Program hosted its 3rd symposium on ‘Emerging Technologies in Organoid Research’ on Thursday 2nd November 2023 at Monash University, Clayton Campus.
With more than 200 registrants, the Symposium welcomed research staff, students and industry professionals from across Australia. The event provided the opportunity for attendees to learn and share new techniques used in organoid research and network with other’s from various research institution and companies.
This year, the organising committee decided to allocate more time to each speaker, giving the opportunity to go more in depth about their unique technics and also share multiple tips and tricks with the audience. Equally important, this allowed more time for questions, the starting point of many interesting discussions that kept developing further during the networking breaks.
The main themes covered on the day included fundamental organoid methodologies, engineering models, tissue and disease modelling and precision medicine.
The new addition this year was the technical talks from the sponsors Revvity and Teccan who shared some exciting videos of the latest innovative robotic technologies in term of organoid culture and imaging automatization.
The ‘Coffee on Cue’ coffee cart was also an event highlight, it was made possible thanks to the generosity of their Sponsors, and it kept providing attendees with barrister made coffees all day. The event sponsors included Bio-strategy, Corning, millennium Science, Revvity, Sartorius, Stem Cell Technologies and Tecan. Thanks to these companies, it was possible for the symposium to be a free, fully catered event which was greatly appreciated by the attendees.
The attendees enjoyed the “great breadth of speakers from around the country. (it) Made it very interesting and unique!”. They also appreciated the “high level of engagement from researchers and industries” and “the range of topics discussed and the ability to chat to relevant companies about organoid tools and techniques”.
The event was overall a great success and the feedback has been overwhelmingly positive. 92.7% of the attendees gained valuable knowledge for their own research and 97.6% of them are looking forward to participating in the next Symposium. The Organoid Program was thrilled to be granted with attendees’ comments such as “Best symposium of the year” or “Congratulations to the organizers for such a wonderful workshop, looking forward to the next one!”
This was the third method focus organoid symposium hosted by the program and certainly not the last. The Organoid Program can already announce the date of the next event: 7th of November 2024, and they will be delighted to host Prof Karuna Ganesh as their Keynote speaker. After listening to their attendees’ valuable feedback, the next edition may incorporate a few changes such as a poster/social mixer session, short talk from students and cover new topics possibly including tissue regeneration, drug screening, infectious diseases and immunology.
Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers In Vitro services through a collaborative consortium of ten laboratories and facilities across Australia, operating at ANU (ANU Centre for Therapeutic Discovery), Perkins (Translational Cancer Research Program in Oncology), Monash (Monash Organoid Program & Monash Genome Modification Platform), MCRI (iPSC derivation & Gene Editing Facility), Peter Mac (Victorian Centre for Functional Genomics), UMelb (Centre for Stem Cell Systems & Stem Cell Disease Modelling Laboratory), UQ (In vitro Genome Engineering and Disease Modelling Service), and VCCRI (Stem Cell Production Facility iPSC Reprogramming Service)